<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">33953791</PMID><DateCompleted><Year>2021</Year><Month>09</Month><Day>24</Day></DateCompleted><DateRevised><Year>2021</Year><Month>12</Month><Day>04</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">1748-6718</ISSN><JournalIssue CitedMedium="Internet"><Volume>2021</Volume><PubDate><Year>2021</Year></PubDate></JournalIssue><Title>Computational and mathematical methods in medicine</Title><ISOAbbreviation>Comput Math Methods Med</ISOAbbreviation></Journal><ArticleTitle>The Novel Regulatory Role of lncRNA-miRNA-mRNA Axis in Amyotrophic Lateral Sclerosis: An Integrated Bioinformatics Analysis.</ArticleTitle><Pagination><StartPage>5526179</StartPage><MedlinePgn>5526179</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">5526179</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1155/2021/5526179</ELocationID><Abstract><AbstractText>Amyotrophic lateral sclerosis (ALS) is an incurable neurodegenerative disease that primarily affects motor neurons, causing muscle atrophy, bulbar palsy, and pyramidal tract signs. However, the aetiology and pathogenesis of ALS have not been elucidated to date. In this study, a competitive endogenous RNA (ceRNA) network was constructed by analyzing the expression profiles of messenger RNAs (mRNAs) and long noncoding RNAs (lncRNAs) that were matched by 7 ALS samples and 4 control samples, and then a protein-protein interaction (PPI) network was constructed to identify the genes related to ALS. Gene Ontology (GO) was used to study the potential functions of differentially expressed mRNAs (DEmRNAs) in the ceRNA network. For the ALS and control groups, 247177 potential lncRNA-mRNA ceRNA relationship pairs were screened. Analysis of significant relationship pairs demonstrated that the PPI modules formed by the <i>MALAT1</i>-regulated <i>SYNRG</i>, <i>ITSN2</i>, <i>PICALM</i>, <i>AP3B1</i>, and <i>AAK1</i> genes may play important roles in the pathogenesis of ALS, and these results may help to characterize the pathogenesis of ALS.</AbstractText><CopyrightInformation>Copyright &#xa9; 2021 Dingsheng Liu et al.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>Dingsheng</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Department of Oncology and Hematology, Shanghai University of Medicine and Health Sciences Affiliated Zhoupu Hospital, Shanghai, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zuo</LastName><ForeName>Xiaojia</ForeName><Initials>X</Initials><Identifier Source="ORCID">0000-0002-1838-9312</Identifier><AffiliationInfo><Affiliation>Department of Oncology and Hematology, Shanghai University of Medicine and Health Sciences Affiliated Zhoupu Hospital, Shanghai, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Peng</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Shanghai Key Laboratory of Molecular Imaging, Shanghai University of Medicine and Health Sciences, Shanghai, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhao</LastName><ForeName>Rui</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Shanghai Key Laboratory of Molecular Imaging, Shanghai University of Medicine and Health Sciences, Shanghai, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lai</LastName><ForeName>Donglin</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Shanghai Key Laboratory of Molecular Imaging, Shanghai University of Medicine and Health Sciences, Shanghai, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>Kaijie</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Shanghai Key Laboratory of Molecular Imaging, Shanghai University of Medicine and Health Sciences, Shanghai, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Han</LastName><ForeName>Yuru</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Shanghai Key Laboratory of Molecular Imaging, Shanghai University of Medicine and Health Sciences, Shanghai, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wan</LastName><ForeName>Guoqing</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Shanghai Key Laboratory of Molecular Imaging, Shanghai University of Medicine and Health Sciences, Shanghai, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zheng</LastName><ForeName>Yanjun</ForeName><Initials>Y</Initials><Identifier Source="ORCID">0000-0002-1943-5106</Identifier><AffiliationInfo><Affiliation>Shanghai Key Laboratory of Molecular Imaging, Shanghai University of Medicine and Health Sciences, Shanghai, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lu</LastName><ForeName>Changlian</ForeName><Initials>C</Initials><Identifier Source="ORCID">0000-0002-0812-9162</Identifier><AffiliationInfo><Affiliation>Shanghai Key Laboratory of Molecular Imaging, Shanghai University of Medicine and Health Sciences, Shanghai, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gu</LastName><ForeName>Xuefeng</ForeName><Initials>X</Initials><Identifier Source="ORCID">0000-0002-8718-2067</Identifier><AffiliationInfo><Affiliation>Shanghai Key Laboratory of Molecular Imaging, Shanghai University of Medicine and Health Sciences, Shanghai, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Research Department, Shanghai University of Medicine and Health Sciences Affiliated Zhoupu Hospital, Shanghai, China.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2021</Year><Month>04</Month><Day>15</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Comput Math Methods Med</MedlineTA><NlmUniqueID>101277751</NlmUniqueID><ISSNLinking>1748-670X</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C557041">MALAT1 long non-coding RNA, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D035683">MicroRNAs</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D062085">RNA, Long Noncoding</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D012333">RNA, Messenger</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 2.7.11.1</RegistryNumber><NameOfSubstance UI="C451304">AAK1 protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 2.7.11.1</RegistryNumber><NameOfSubstance UI="D017346">Protein Serine-Threonine Kinases</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="N">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016022" MajorTopicYN="N">Case-Control Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019295" MajorTopicYN="N">Computational Biology</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005786" MajorTopicYN="N">Gene Expression Regulation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D063990" MajorTopicYN="N">Gene Ontology</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D053263" MajorTopicYN="N">Gene Regulatory Networks</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D035683" MajorTopicYN="N">MicroRNAs</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D060066" MajorTopicYN="N">Protein Interaction Maps</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017346" MajorTopicYN="N">Protein Serine-Threonine Kinases</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D062085" MajorTopicYN="N">RNA, Long Noncoding</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012333" MajorTopicYN="N">RNA, Messenger</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName></MeshHeading></MeshHeadingList><CoiStatement>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2021</Year><Month>1</Month><Day>8</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2021</Year><Month>3</Month><Day>2</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2021</Year><Month>3</Month><Day>5</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>5</Month><Day>6</Day><Hour>7</Hour><Minute>3</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>5</Month><Day>7</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>9</Month><Day>25</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">33953791</ArticleId><ArticleId IdType="pmc">PMC8067776</ArticleId><ArticleId IdType="doi">10.1155/2021/5526179</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Saucier D., Wajnberg G., Roy J., et al. Identification of a circulating miRNA signature in extracellular vesicles collected from amyotrophic lateral sclerosis patients. Brain Research. 2019;1708:100&#x2013;108. doi: 10.1016/j.brainres.2018.12.016.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.brainres.2018.12.016</ArticleId><ArticleId IdType="pubmed">30552897</ArticleId></ArticleIdList></Reference><Reference><Citation>McCann E. P., Henden L., Fifita J. A., et al. Evidence for polygenic and oligogenic basis of Australian sporadic amyotrophic lateral sclerosis. Journal of Medical Genetics. 2021;58:87&#x2013;95.</Citation><ArticleIdList><ArticleId IdType="pubmed">32409511</ArticleId></ArticleIdList></Reference><Reference><Citation>Kosuge Y., Nango H., Kasai H., et al. Generation of cellular reactive oxygen species by activation of the EP2 receptor contributes to prostaglandin E2-induced cytotoxicity in motor neuron-like NSC-34 cells. Oxidative Medicine and Cellular Longevity. 2020;2020:14. doi: 10.1155/2020/6101838.6101838</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2020/6101838</ArticleId><ArticleId IdType="pmc">PMC7201578</ArticleId><ArticleId IdType="pubmed">32411331</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang Y. J., Guo L., Gonzales P. K., et al. Heterochromatin anomalies and double-stranded RNA accumulation underlie C9orf72 poly(PR) toxicity. Science. 2019;363(6428, article eaav2606) doi: 10.1126/science.aav2606.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.aav2606</ArticleId><ArticleId IdType="pmc">PMC6524780</ArticleId><ArticleId IdType="pubmed">30765536</ArticleId></ArticleIdList></Reference><Reference><Citation>Jimenez-Pacheco A., Franco J. M., Lopez S., et al. Epigenetic mechanisms of gene regulation in amyotrophic lateral sclerosis. Advances in Experimental Medicine and Biology. 2017;978:255&#x2013;275. doi: 10.1007/978-3-319-53889-1_14.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/978-3-319-53889-1_14</ArticleId><ArticleId IdType="pubmed">28523551</ArticleId></ArticleIdList></Reference><Reference><Citation>Maruyama H., Morino H., Ito H., et al. Mutations of optineurin in amyotrophic lateral sclerosis. Nature. 2010;465(7295):223&#x2013;226. doi: 10.1038/nature08971.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature08971</ArticleId><ArticleId IdType="pubmed">20428114</ArticleId></ArticleIdList></Reference><Reference><Citation>Beers D. R., Appel S. H. Immune dysregulation in amyotrophic lateral sclerosis: mechanisms and emerging therapies. The Lancet Neurology. 2019;18(2):211&#x2013;220. doi: 10.1016/S1474-4422(18)30394-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1474-4422(18)30394-6</ArticleId><ArticleId IdType="pubmed">30663610</ArticleId></ArticleIdList></Reference><Reference><Citation>Burberry A., Wells M. F., Limone F., et al. C9orf72 suppresses systemic and neural inflammation induced by gut bacteria. Nature. 2020;582(7810):89&#x2013;94. doi: 10.1038/s41586-020-2288-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-020-2288-7</ArticleId><ArticleId IdType="pmc">PMC7416879</ArticleId><ArticleId IdType="pubmed">32483373</ArticleId></ArticleIdList></Reference><Reference><Citation>Petit C. S., Lee J. J., Boland S., et al. Inhibition of sphingolipid synthesis improves outcomes and survival in GARP mutant wobbler mice, a model of motor neuron degeneration. Proceedings of the National Academy of Sciences of the United States of America. 2020;117(19):10565&#x2013;10574. doi: 10.1073/pnas.1913956117.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1913956117</ArticleId><ArticleId IdType="pmc">PMC7229683</ArticleId><ArticleId IdType="pubmed">32345721</ArticleId></ArticleIdList></Reference><Reference><Citation>Cuajungco M. P., Lees G. J. Zinc metabolism in the brain: relevance to human neurodegenerative disorders. Neurobiology of Disease. 1997;4(3-4):137&#x2013;169. doi: 10.1006/nbdi.1997.0163.</Citation><ArticleIdList><ArticleId IdType="doi">10.1006/nbdi.1997.0163</ArticleId><ArticleId IdType="pubmed">9361293</ArticleId></ArticleIdList></Reference><Reference><Citation>Deng H. X., Chen W., Hong S. T., et al. Mutations in UBQLN2 cause dominant X-linked juvenile and adult-onset ALS and ALS/dementia. Nature. 2011;477(7363):211&#x2013;215. doi: 10.1038/nature10353.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature10353</ArticleId><ArticleId IdType="pmc">PMC3169705</ArticleId><ArticleId IdType="pubmed">21857683</ArticleId></ArticleIdList></Reference><Reference><Citation>Dion P. A., Daoud H., Rouleau G. A. Genetics of motor neuron disorders: new insights into pathogenic mechanisms. Nature Reviews Genetics. 2009;10(11):769&#x2013;782. doi: 10.1038/nrg2680.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrg2680</ArticleId><ArticleId IdType="pubmed">19823194</ArticleId></ArticleIdList></Reference><Reference><Citation>Maruyama H., Kawakami H. Optineurin and amyotrophic lateral sclerosis. Geriatrics &amp; Gerontology International. 2013;13(3):528&#x2013;532. doi: 10.1111/ggi.12022.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/ggi.12022</ArticleId><ArticleId IdType="pubmed">23279185</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu C. H., Fallini C., Ticozzi N., et al. Mutations in the profilin 1 gene cause familial amyotrophic lateral sclerosis. Nature. 2012;488(7412):499&#x2013;503. doi: 10.1038/nature11280.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature11280</ArticleId><ArticleId IdType="pmc">PMC3575525</ArticleId><ArticleId IdType="pubmed">22801503</ArticleId></ArticleIdList></Reference><Reference><Citation>Osmanovic A., Widjaja M., F&#xf6;rster A., et al. SPG7 mutations in amyotrophic lateral sclerosis: a genetic link to hereditary spastic paraplegia. Journal of Neurology. 2020;267(9):2732&#x2013;2743. doi: 10.1007/s00415-020-09861-w.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00415-020-09861-w</ArticleId><ArticleId IdType="pmc">PMC7419373</ArticleId><ArticleId IdType="pubmed">32447552</ArticleId></ArticleIdList></Reference><Reference><Citation>Xue Y. C., Ng C. S., Xiang P., et al. Dysregulation of RNA-binding proteins in amyotrophic lateral sclerosis. Frontiers in Molecular Neuroscience. 2020;13:p. 78. doi: 10.3389/fnmol.2020.00078.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnmol.2020.00078</ArticleId><ArticleId IdType="pmc">PMC7273501</ArticleId><ArticleId IdType="pubmed">32547363</ArticleId></ArticleIdList></Reference><Reference><Citation>Waller R., Wyles M., Heath P. R., et al. Small RNA sequencing of sporadic amyotrophic lateral sclerosis cerebrospinal fluid reveals differentially expressed miRNAs related to neural and glial activity. Frontiers in Neuroscience. 2017;11:p. 731. doi: 10.3389/fnins.2017.00731.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnins.2017.00731</ArticleId><ArticleId IdType="pmc">PMC5767269</ArticleId><ArticleId IdType="pubmed">29375285</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen Y. P., Wei Q. Q., Chen X. P., et al. Aberration of miRNAs expression in leukocytes from sporadic amyotrophic lateral sclerosis. Frontiers in Molecular Neuroscience. 2016;9:p. 69. doi: 10.3389/fnmol.2016.00069.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnmol.2016.00069</ArticleId><ArticleId IdType="pmc">PMC4987348</ArticleId><ArticleId IdType="pubmed">27582688</ArticleId></ArticleIdList></Reference><Reference><Citation>Dardiotis E., Aloizou A. M., Siokas V., et al. The role of microRNAs in patients with amyotrophic lateral sclerosis. Journal of Molecular Neuroscience. 2018;66(4):617&#x2013;628. doi: 10.1007/s12031-018-1204-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12031-018-1204-1</ArticleId><ArticleId IdType="pubmed">30415446</ArticleId></ArticleIdList></Reference><Reference><Citation>Helferich A. M., Brockmann S. J., Reinders J., et al. Dysregulation of a novel miR-1825/TBCB/TUBA4A pathway in sporadic and familial ALS. Cellular and Molecular Life Sciences. 2018;75(23):4301&#x2013;4319. doi: 10.1007/s00018-018-2873-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00018-018-2873-1</ArticleId><ArticleId IdType="pubmed">30030593</ArticleId></ArticleIdList></Reference><Reference><Citation>Gagliardi S., Zucca S., Pandini C., et al. Long non-coding and coding RNAs characterization in peripheral blood mononuclear cells and spinal cord from amyotrophic lateral sclerosis patients. Scientific Reports. 2018;8(1, article 2378) doi: 10.1038/s41598-018-20679-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-018-20679-5</ArticleId><ArticleId IdType="pmc">PMC5799454</ArticleId><ArticleId IdType="pubmed">29402919</ArticleId></ArticleIdList></Reference><Reference><Citation>Katsu M., Hama Y., Utsumi J., et al. MicroRNA expression profiles of neuron-derived extracellular vesicles in plasma from patients with amyotrophic lateral sclerosis. Neuroscience Letters. 2019;708, article 134176 doi: 10.1016/j.neulet.2019.03.048.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neulet.2019.03.048</ArticleId><ArticleId IdType="pubmed">31173847</ArticleId></ArticleIdList></Reference><Reference><Citation>de Felice B., Guida M., Guida M., Coppola C., de Mieri G., Cotrufo R. A miRNA signature in leukocytes from sporadic amyotrophic lateral sclerosis. Gene. 2012;508(1):35&#x2013;40. doi: 10.1016/j.gene.2012.07.058.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.gene.2012.07.058</ArticleId><ArticleId IdType="pubmed">22903028</ArticleId></ArticleIdList></Reference><Reference><Citation>Salmena L., Poliseno L., Tay Y., Kats L., Pandolfi P. P. A ceRNA hypothesis: the Rosetta stone of a hidden RNA language? Cell. 2011;146(3):353&#x2013;358. doi: 10.1016/j.cell.2011.07.014.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2011.07.014</ArticleId><ArticleId IdType="pmc">PMC3235919</ArticleId><ArticleId IdType="pubmed">21802130</ArticleId></ArticleIdList></Reference><Reference><Citation>Sardina D. S., Alaimo S., Ferro A., Pulvirenti A., Giugno R. A novel computational method for inferring competing endogenous interactions. Briefings in Bioinformatics. 2017;18(6):1071&#x2013;1081. doi: 10.1093/bib/bbw084.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/bib/bbw084</ArticleId><ArticleId IdType="pubmed">27677959</ArticleId></ArticleIdList></Reference><Reference><Citation>Tunca C., &#x15e;eker T., Ak&#xe7;imen F., et al. Revisiting the complex architecture of ALS in Turkey: expanding genotypes, shared phenotypes, molecular networks, and a public variant database. Human Mutation. 2020;41(8):e7&#x2013;e45. doi: 10.1002/humu.24055.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/humu.24055</ArticleId><ArticleId IdType="pubmed">32579787</ArticleId></ArticleIdList></Reference><Reference><Citation>Shin J., Salameh J. S., Richter J. D. Impaired neurodevelopment by the low complexity domain of CPEB4 reveals a convergent pathway with neurodegeneration. Scientific Reports. 2016;6(1, article 29395) doi: 10.1038/srep29395.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/srep29395</ArticleId><ArticleId IdType="pmc">PMC4933966</ArticleId><ArticleId IdType="pubmed">27381259</ArticleId></ArticleIdList></Reference><Reference><Citation>Shoemaker C. J., Huang T. Q., Weir N. R., Polyakov N. J., Schultz S. W., Denic V. CRISPR screening using an expanded toolkit of autophagy reporters identifies TMEM41B as a novel autophagy factor. PLoS biology. 2019;17(4, article e2007044) doi: 10.1371/journal.pbio.2007044.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pbio.2007044</ArticleId><ArticleId IdType="pmc">PMC6459555</ArticleId><ArticleId IdType="pubmed">30933966</ArticleId></ArticleIdList></Reference><Reference><Citation>Garc&#xed;a-Morales V., Rodr&#xed;guez-Bey G., G&#xf3;mez-P&#xe9;rez L., et al. Sp1-regulated expression of p11 contributes to motor neuron degeneration by membrane insertion of TASK1. Nature Communications. 2019;10(1, article 3784) doi: 10.1038/s41467-019-11637-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-019-11637-4</ArticleId><ArticleId IdType="pmc">PMC6706379</ArticleId><ArticleId IdType="pubmed">31439839</ArticleId></ArticleIdList></Reference><Reference><Citation>Otomo A., Hadano S., Okada T., et al. ALS2, a novel guanine nucleotide exchange factor for the small GTPase Rab5, is implicated in endosomal dynamics. Human Molecular Genetics. 2003;12(14):1671&#x2013;1687. doi: 10.1093/hmg/ddg184.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddg184</ArticleId><ArticleId IdType="pubmed">12837691</ArticleId></ArticleIdList></Reference><Reference><Citation>Gonzalez de Aguilar J. L., Niederhauser-Wiederkehr C., Halter B., et al. Gene profiling of skeletal muscle in an amyotrophic lateral sclerosis mouse model. Physiological Genomics. 2008;32(2):207&#x2013;218. doi: 10.1152/physiolgenomics.00017.2007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/physiolgenomics.00017.2007</ArticleId><ArticleId IdType="pubmed">18000159</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang C., Yang Y., Liang W., et al. Neuroprotection by urate on the mutant hSOD1-related cellular and Drosophila models of amyotrophic lateral sclerosis: implication for GSH synthesis via activating Akt/GSK3&#x3b2;/Nrf2/GCLC pathways. Brain Research Bulletin. 2019;146:287&#x2013;301. doi: 10.1016/j.brainresbull.2019.01.019.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.brainresbull.2019.01.019</ArticleId><ArticleId IdType="pubmed">30690059</ArticleId></ArticleIdList></Reference><Reference><Citation>Tollervey J. R., Curk T., Rogelj B., et al. Characterizing the RNA targets and position-dependent splicing regulation by TDP-43. Nature Neuroscience. 2011;14(4):452&#x2013;458. doi: 10.1038/nn.2778.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nn.2778</ArticleId><ArticleId IdType="pmc">PMC3108889</ArticleId><ArticleId IdType="pubmed">21358640</ArticleId></ArticleIdList></Reference><Reference><Citation>Lagier-Tourenne C., Cleveland D. W. Rethinking ALS: the FUS about TDP-43. Cell. 2009;136(6):1001&#x2013;1004. doi: 10.1016/j.cell.2009.03.006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2009.03.006</ArticleId><ArticleId IdType="pmc">PMC3110083</ArticleId><ArticleId IdType="pubmed">19303844</ArticleId></ArticleIdList></Reference><Reference><Citation>Elden A. C., Kim H. J., Hart M. P., et al. Ataxin-2 intermediate-length polyglutamine expansions are associated with increased risk for ALS. Nature. 2010;466(7310):1069&#x2013;1075. doi: 10.1038/nature09320.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature09320</ArticleId><ArticleId IdType="pmc">PMC2965417</ArticleId><ArticleId IdType="pubmed">20740007</ArticleId></ArticleIdList></Reference><Reference><Citation>Kabashi E., Valdmanis P. N., Dion P., et al. TARDBP mutations in individuals with sporadic and familial amyotrophic lateral sclerosis. Nature Genetics. 2008;40(5):572&#x2013;574. doi: 10.1038/ng.132.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ng.132</ArticleId><ArticleId IdType="pubmed">18372902</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim H. J., Kim N. C., Wang Y. D., et al. Mutations in prion-like domains in hnRNPA2B1 and hnRNPA1 cause multisystem proteinopathy and ALS. Nature. 2013;495(7442):467&#x2013;473. doi: 10.1038/nature11922.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature11922</ArticleId><ArticleId IdType="pmc">PMC3756911</ArticleId><ArticleId IdType="pubmed">23455423</ArticleId></ArticleIdList></Reference><Reference><Citation>Martinez F. J., Pratt G. A., van Nostrand E. L., et al. Protein-RNA networks regulated by Normal and ALS-associated mutant HNRNPA2B1 in the nervous system. Neuron. 2016;92(4):780&#x2013;795. doi: 10.1016/j.neuron.2016.09.050.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2016.09.050</ArticleId><ArticleId IdType="pmc">PMC5123850</ArticleId><ArticleId IdType="pubmed">27773581</ArticleId></ArticleIdList></Reference><Reference><Citation>Qi X., Pang Q., Wang J., et al. Familial early-onset Paget's disease of bone associated with a novel hnRNPA2B1 mutation. Calcified Tissue International. 2017;101(2):159&#x2013;169. doi: 10.1007/s00223-017-0269-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00223-017-0269-0</ArticleId><ArticleId IdType="pubmed">28389692</ArticleId></ArticleIdList></Reference><Reference><Citation>Seelen M., Visser A. E., Overste D. J., et al. No mutations in hnRNPA1 and hnRNPA2B1 in Dutch patients with amyotrophic lateral sclerosis, frontotemporal dementia, and inclusion body myopathy. Neurobiology of Aging. 2014;35(8):1956.e9&#x2013;1956.e11. doi: 10.1016/j.neurobiolaging.2014.01.152.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neurobiolaging.2014.01.152</ArticleId><ArticleId IdType="pubmed">24612671</ArticleId></ArticleIdList></Reference><Reference><Citation>Inoue H., Tsukita K., Iwasato T., et al. The crucial role of caspase-9 in the disease progression of a transgenic ALS mouse model. The EMBO Journal. 2003;22(24):6665&#x2013;6674. doi: 10.1093/emboj/cdg634.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/emboj/cdg634</ArticleId><ArticleId IdType="pmc">PMC291829</ArticleId><ArticleId IdType="pubmed">14657037</ArticleId></ArticleIdList></Reference><Reference><Citation>Kadoyama K., Funakoshi H., Ohya W., Nakamura T. Hepatocyte growth factor (HGF) attenuates gliosis and motoneuronal degeneration in the brainstem motor nuclei of a transgenic mouse model of ALS. Neuroscience Research. 2007;59(4):446&#x2013;456. doi: 10.1016/j.neures.2007.08.017.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neures.2007.08.017</ArticleId><ArticleId IdType="pubmed">17935811</ArticleId></ArticleIdList></Reference><Reference><Citation>Pyo J. S., Ko Y. S., Kim W. H., et al. Impairment of nuclear factor-kappaB activation increased glutamate excitotoxicity in a motoneuron-neuroblastoma hybrid cell line expressing mutant (G93A) Cu/Zn-superoxide dismutase. Journal of Neuroscience Research. 2010;88(11):2494&#x2013;2503. doi: 10.1002/jnr.22397.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jnr.22397</ArticleId><ArticleId IdType="pubmed">20623531</ArticleId></ArticleIdList></Reference><Reference><Citation>Tokuda E., Ono S., Ishige K., et al. Dysequilibrium between caspases and their inhibitors in a mouse model for amyotrophic lateral sclerosis. Brain Research. 2007;1148:234&#x2013;242. doi: 10.1016/j.brainres.2007.02.087.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.brainres.2007.02.087</ArticleId><ArticleId IdType="pubmed">17397813</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang Y. Q., Zheng Y. H., Zhang C. T., et al. Wild-type p53-induced phosphatase 1 down-regulation promotes apoptosis by activating the DNA damage-response pathway in amyotrophic lateral sclerosis. Neurobiology of Disease. 2020;134, article 104648 doi: 10.1016/j.nbd.2019.104648.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nbd.2019.104648</ArticleId><ArticleId IdType="pubmed">31676238</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim B. W., Jeong Y. E., Wong M., Martin L. J. DNA damage accumulates and responses are engaged in human ALS brain and spinal motor neurons and DNA repair is activatable in iPSC-derived motor neurons with SOD1 mutations. Acta Neuropathologica Communications. 2020;8(1):p. 7. doi: 10.1186/s40478-019-0874-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40478-019-0874-4</ArticleId><ArticleId IdType="pmc">PMC6995159</ArticleId><ArticleId IdType="pubmed">32005289</ArticleId></ArticleIdList></Reference><Reference><Citation>Rodriguez-Fraticelli A. E., Vergarajauregui S., Eastburn D. J., et al. The Cdc42 GEF intersectin 2 controls mitotic spindle orientation to form the lumen during epithelial morphogenesis. The Journal of Cell Biology. 2010;189(4):725&#x2013;738. doi: 10.1083/jcb.201002047.</Citation><ArticleIdList><ArticleId IdType="doi">10.1083/jcb.201002047</ArticleId><ArticleId IdType="pmc">PMC2872911</ArticleId><ArticleId IdType="pubmed">20479469</ArticleId></ArticleIdList></Reference><Reference><Citation>Sengar A. S., Ellegood J., Yiu A. P., et al. Vertebrate intersectin1 is repurposed to facilitate cortical midline connectivity and higher order cognition. The Journal of Neuroscience. 2013;33(9):4055&#x2013;4065. doi: 10.1523/JNEUROSCI.4428-12.2013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.4428-12.2013</ArticleId><ArticleId IdType="pmc">PMC6619305</ArticleId><ArticleId IdType="pubmed">23447614</ArticleId></ArticleIdList></Reference><Reference><Citation>Shi B., Conner S. D., Liu J. Dysfunction of endocytic kinase AAK1 in ALS. International Journal of Molecular Sciences. 2014;15(12):22918&#x2013;22932. doi: 10.3390/ijms151222918.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms151222918</ArticleId><ArticleId IdType="pmc">PMC4284746</ArticleId><ArticleId IdType="pubmed">25514244</ArticleId></ArticleIdList></Reference><Reference><Citation>Hendrix N. W., Clemens M., Canavan T. P., Surti U., Rajkovic A. Prenatally diagnosed 17q12 microdeletion syndrome with a novel association with congenital diaphragmatic hernia. Fetal Diagnosis and Therapy. 2012;31(2):129&#x2013;133. doi: 10.1159/000332968.</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000332968</ArticleId><ArticleId IdType="pubmed">22178801</ArticleId></ArticleIdList></Reference><Reference><Citation>Yamamoto H., Hayakawa F., Yasuda T., et al. ZNF384-fusion proteins have high affinity for the transcriptional coactivator EP300 and aberrant transcriptional activities. FEBS Letters. 2019;593(16):2151&#x2013;2161. doi: 10.1002/1873-3468.13506.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/1873-3468.13506</ArticleId><ArticleId IdType="pubmed">31234226</ArticleId></ArticleIdList></Reference><Reference><Citation>Harold D., Abraham R., Hollingworth P., et al. Genome-wide association study identifies variants at CLU and PICALM associated with Alzheimer's disease. Nature Genetics. 2009;41(10):1088&#x2013;1093. doi: 10.1038/ng.440.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ng.440</ArticleId><ArticleId IdType="pmc">PMC2845877</ArticleId><ArticleId IdType="pubmed">19734902</ArticleId></ArticleIdList></Reference><Reference><Citation>Seshadri S., Fitzpatrick A. L., Ikram M. A., et al. Genome-wide analysis of genetic loci associated with Alzheimer disease. JAMA. 2010;303(18):1832&#x2013;1840. doi: 10.1001/jama.2010.574.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2010.574</ArticleId><ArticleId IdType="pmc">PMC2989531</ArticleId><ArticleId IdType="pubmed">20460622</ArticleId></ArticleIdList></Reference><Reference><Citation>van Es M. A., van den Berg L. H. Alzheimer's disease beyond APOE. Nature Genetics. 2009;41(10):1047&#x2013;1048. doi: 10.1038/ng1009-1047.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ng1009-1047</ArticleId><ArticleId IdType="pubmed">19786950</ArticleId></ArticleIdList></Reference><Reference><Citation>Jing R., Kong Y., Han G., et al. The mutation of the Ap3b1 gene causes uterine hypoplasia in pearl mice. Reproductive Sciences. 2020;27(1):182&#x2013;191. doi: 10.1007/s43032-019-00006-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s43032-019-00006-7</ArticleId><ArticleId IdType="pubmed">32016796</ArticleId></ArticleIdList></Reference><Reference><Citation>Gon&#xe7;alves E., Fragoulis A., Garcia-Alonso L., Cramer T., Saez-Rodriguez J., Beltrao P. Widespread post-transcriptional attenuation of genomic copy-number variation in cancer. Cell systems. 2017;5(4):386&#x2013;398.e4. doi: 10.1016/j.cels.2017.08.013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cels.2017.08.013</ArticleId><ArticleId IdType="pmc">PMC5660600</ArticleId><ArticleId IdType="pubmed">29032074</ArticleId></ArticleIdList></Reference><Reference><Citation>de Boer M., van Leeuwen K., Geissler J., et al. Hermansky-Pudlak syndrome type 2: aberrant pre-mRNA splicing and mislocalization of granule proteins in neutrophils. Human Mutation. 2017;38(10):1402&#x2013;1411. doi: 10.1002/humu.23271.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/humu.23271</ArticleId><ArticleId IdType="pubmed">28585318</ArticleId></ArticleIdList></Reference><Reference><Citation>Jing R., Zhang H., Kong Y., et al. Different functions of biogenesis of lysosomal organelles complex 3 subunit 1 (Hps1) and adaptor-related protein complex 3, beta 1 subunit (Ap3b1) genes on spermatogenesis and male fertility. Reproduction, Fertility, and Development. 2019;31(5):972&#x2013;982. doi: 10.1071/RD18339.</Citation><ArticleIdList><ArticleId IdType="doi">10.1071/RD18339</ArticleId><ArticleId IdType="pubmed">30786955</ArticleId></ArticleIdList></Reference><Reference><Citation>Karampini E., Schillemans M., Hofman M., et al. Defective AP-3-dependent VAMP8 trafficking impairs Weibel-Palade body exocytosis in Hermansky-Pudlak syndrome type 2 blood outgrowth endothelial cells. Haematologica. 2019;104(10):2091&#x2013;2099. doi: 10.3324/haematol.2018.207787.</Citation><ArticleIdList><ArticleId IdType="doi">10.3324/haematol.2018.207787</ArticleId><ArticleId IdType="pmc">PMC6886443</ArticleId><ArticleId IdType="pubmed">30630984</ArticleId></ArticleIdList></Reference><Reference><Citation>Miao Y., Zhu H. Y., Qiao C., et al. Pathogenic gene mutations or variants identified by targeted gene sequencing in adults with hemophagocytic lymphohistiocytosis. Frontiers in Immunology. 2019;10:p. 395. doi: 10.3389/fimmu.2019.00395.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2019.00395</ArticleId><ArticleId IdType="pmc">PMC6416222</ArticleId><ArticleId IdType="pubmed">30899265</ArticleId></ArticleIdList></Reference><Reference><Citation>Mukda E., Trachoo O., Pasomsub E., et al. Exome sequencing for simultaneous mutation screening in children with hemophagocytic lymphohistiocytosis. International Journal of Hematology. 2017;106(2):282&#x2013;290. doi: 10.1007/s12185-017-2223-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12185-017-2223-3</ArticleId><ArticleId IdType="pubmed">28353193</ArticleId></ArticleIdList></Reference><Reference><Citation>Nishikawa T., Okamura K., Moriyama M., et al. Novel AP3B1 compound heterozygous mutations in a Japanese patient with Hermansky&#x2013;Pudlak syndrome type 2. The Journal of Dermatology. 2020;47(2):185&#x2013;189. doi: 10.1111/1346-8138.15177.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/1346-8138.15177</ArticleId><ArticleId IdType="pubmed">31820501</ArticleId></ArticleIdList></Reference><Reference><Citation>Rubin T. S., Zhang K., Gifford C., et al. Perforin and CD107a testing is superior to NK cell function testing for screening patients for genetic HLH. Blood. 2017;129(22):2993&#x2013;2999. doi: 10.1182/blood-2016-12-753830.</Citation><ArticleIdList><ArticleId IdType="doi">10.1182/blood-2016-12-753830</ArticleId><ArticleId IdType="pmc">PMC5766842</ArticleId><ArticleId IdType="pubmed">28270454</ArticleId></ArticleIdList></Reference><Reference><Citation>Schaletzki Y., Kromrey M. L., Br&#xf6;derdorf S., et al. Several adaptor proteins promote intracellular localisation of the transporter MRP4/ABCC4 in platelets and haematopoietic cells. Thrombosis and Haemostasis. 2017;117(1):105&#x2013;115. doi: 10.1160/TH16-01-0045.</Citation><ArticleIdList><ArticleId IdType="doi">10.1160/TH16-01-0045</ArticleId><ArticleId IdType="pubmed">27761583</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>